A Randomized, Placebo-controlled Phase II Trial Investigating SUNITINIB Versus Placebo in Patients With Chemorefractory Advanced Adenocarcinoma of the Stomach or Lower Esophagus Treated With Chemotherapy FOLFIRI.
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Sunitinib (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms SUN-CASE
- 04 Jun 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 11 Jun 2012 Status changed from active, no longer recruiting to completed as reported by EudraCT.
- 17 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.